COVID-19

This report presents findings of an environmental scan and semi-structured interviews with key contributors, including governmental and non-governmental contributors, such as researchers, clinicians, advocates, service provider/payers, and policy experts. The findings included in this report are organized by specific domains and themes found within the peer-reviewed and grey literature.

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report summarizing lessons learned from using communities of practice (CoPs) to support state, Tribal, local, and territorial (STLT) public health agencies during the COVID-19 pandemic.

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) and the Office of the Assistant Secretary for Health (OASH), in partnership with Mathematica, are conducting a comprehensive study to identify promising practices aimed at reducing disparities in COVID-19 vaccination and testing, and policy options to promote equitable, routine vaccination.

To help the federal government and STLT jurisdictions better prepare for emergencies, there is a need to understand how prepared different jurisdictions are for various emergencies. However, assessing whether a jurisdiction is prepared for different emergencies is inherently complex and there is a lack of consensus among practitioners and scholars on how to approach preparedness measurement.

Nursing homes experienced unprecedented financial challenges during the COVID-19 pandemic, raising concerns about a potential increase in nursing home closures.

Nursing homes have been disproportionately impacted by COVID-19. The purpose of this study was to examine whether there were racial, ethnic, and socioeconomic differences in COVID-19 infection and mortality rates at both the nursing home resident and nursing home facility levels. The study includes national data on COVID-19 outcomes for nursing home residents through the end of June 2021.

This environmental scan, conducted by Mathematica and funded by ASPE, examines the types of direct and direct costs to patients associated with clinical trial participation. It also explores the effect of COVID-19 on costs to patients, including cost implications of clinical trial innovations widely implemented during COVID-19 and other efforts to increase diversity of clinical trials.

In 2023, ASPE launched a research project to understand the impacts of COVID-19 on the clinical trial enterprise and identify key lessons learned.

States may use Appendix K to modify their existing Medicaid home and community-based services (HCBS) 1915(c) waiver programs during emergency situations. During the COVID-19 public health emergency, states used Appendix K to make temporary changes to access and eligibility, payment, services, and other aspects of their waiver programs.

This Issue Brief explores telehealth use for people and Medicare beneficiaries with disabilities and examines questions on the use of audio-only telehealth during the second and third years of the coronavirus disease 2019 (COVID-19) pandemic.